CARY ETF

$20.81
Unlock Sector Analysis
See detailed sector breakdown, concentration levels, and industry allocation
Unlock Now →

Sector Concentration Analysis

Top 3 Sectors
••.•%
of total portfolio
Concentration Level
••••
concentration risk
Largest Sector
••.•%
••••••••

Sector Allocation

Sector Breakdown

SectorHoldingsWeight
••••••••
7530.00%
••••••••
6520.00%
••••••••
6018.00%
••••••••
5015.00%
••••••••
4512.00%

Industry Breakdown

Top 15 industries by allocation

CARY ETF Sector Allocation

CARY sector allocation breaks down across Unknown (21.0%). Across 670 holdings, this breakdown reveals the ETF's investment focus and diversification.

CARY sector exposure is important for understanding concentration risk. The fund shows reasonable diversification across sectors.

CARY geographic allocation shows country exposure. CARY overlap calculator reveals how sector exposure compares with other funds.

CARY ETF Sector Allocation

Sector Concentration Analysis

Top 3 Sectors

14.1%

of total portfolio

Concentration Level

Low

concentration risk

Largest Sector

11.5%

Financials

Loading chart...

Sector Breakdown

  • 1Financials
    11.53%
  • 2Materials
    1.30%
  • 3Energy
    1.26%
  • 4Industrials
    0.99%
  • 5Consumer Staples
    0.84%
  • 6Health Care
    0.70%
  • 7Consumer Discretionary
    0.69%
  • 8Real Estate
    0.58%
  • 9Communication Services
    0.57%
  • 10Information Technology
    0.55%
  • 11Utilities
    0.23%

Industry Breakdown (Top 15)

Thrifts & Mortgage Finance
3.9%
16 holdings
Specialized Finance
3.6%
45 holdings
Mortgage REITs
1.7%
10 holdings
Asset Management & Custody Banks
0.8%
2 holdings
Oil & Gas Storage & Transportation
0.7%
13 holdings
Packaged Foods & Meats
0.5%
12 holdings
Diversified Capital Markets
0.4%
4 holdings
Consumer Finance
0.4%
5 holdings
Copper
0.4%
4 holdings
Diversified Banks
0.3%
7 holdings
Oil & Gas Exploration & Production
0.3%
5 holdings
Construction & Engineering
0.3%
4 holdings
Construction Materials
0.2%
3 holdings
Electric Utilities
0.2%
5 holdings
Pharmaceuticals
0.2%
4 holdings